A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV
about
Hyperosmolarity impedes the cross-priming competence of dendritic cells in a TRIF-dependent manner.Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.Respiratory syncytial virus: prospects for new and emerging therapeutics.
P2860
A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel influenza virus hemagg ...... cine against influenza and RSV
@en
A novel influenza virus hemagglutinin-respiratory syncytial virus
@nl
type
label
A novel influenza virus hemagg ...... cine against influenza and RSV
@en
A novel influenza virus hemagglutinin-respiratory syncytial virus
@nl
prefLabel
A novel influenza virus hemagg ...... cine against influenza and RSV
@en
A novel influenza virus hemagglutinin-respiratory syncytial virus
@nl
P2093
P2860
P356
P1433
P1476
A novel influenza virus hemagg ...... cine against influenza and RSV
@en
P2093
Les P Jones
Ralph A Tripp
S Mark Tompkins
Tiffany M Turner
P2860
P304
10792-10804
P356
10.1128/JVI.01724-13
P407
P577
2013-07-31T00:00:00Z